Skip to main content

FDA Clears Alfa Scientific's Colorectal Cancer Immunoassay

NEW YORK (360Dx) – Alfa Scientific Designs today announced the US Food and Drug Administration has cleared the company's immunoassay fecal occult blood test.

The iFOB test identifies human blood in feces, which may be a symptom of precancerous polyps and colorectal cancer. It uses one drop of sample solution and provides results in as little as one minute, five times quicker than with standard lateral flow assays, Alfa Scientific said.

iFOB leverages the company's Driven Flow technology, which uses a tighly restricted sample flow path and an additional flow acceleration, creating a drive force to push the flow past the reaction area evenly at high speed with maximum, thorough reaction of the binding complexes, Alfa Scientific said on on its website. It added that the technology provides a self-washing function that minimizes non-specific binding in the reaction area.